Estramustine Unknown Status Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003066Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer